Semaglutide has a chemical structure that is very similar to the
hormone glucagon-like peptide 1 , which regulates both insulin
secretion and appetite. In December, the US Food and Drug
Administration approved the semaglutide injection Ozempic as a
once-weekly adjunct to diet and exercise to improve glycemic
control in adults with type 2 diabetes.
Semaglutide may help people with obesity lose weight. A compound
that mimics a naturally occurring hormone that regulates appetite
may help people who have obesity but not diabetes to lose weight, a
new study suggests.